Aspirin chemoprevention: One size does not fit all

Circulation

Volumn 117, Issue 22, 2008, Pages 2844-2846

  Mosca, Lori ^a,b  

^a Columbia University ^*  (United States)

^b Department of Medicine   (United States)

Author keywords

Aspirin; Cardiovascular diseases; Cost benefit analysis; Editorials; Prevention; Women

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; DIPYRIDAMOLE; PACLITAXEL; RAPAMYCIN;

ARTERY DISEASE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHEMOPROPHYLAXIS; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DRUG ELUTING STENT; EDITORIAL; HEART INFARCTION; HUMAN; MONOTHERAPY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SEX DIFFERENCE; STROKE; TRANSIENT ISCHEMIC ATTACK;

ASPIRIN; CARDIOVASCULAR DISEASES; CHEMOPREVENTION; FEMALE; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; SEX FACTORS;

EID: 44649181173     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.778407     Document Type: Editorial

References (19)

1. The History of Aspirin. Available at: http:///www.bayeraspirin.com/ asp_history.htm. Accessed April 14, 2008.
2. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med. 1989;321:129-135.
3. American Heart Association. Aspirin in heart attack and stroke prevention. Available at: http://www.americanheart.org/presenter.jhtml? identifier=4456. Accessed April 14, 2008.
4. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Greenland P, Grundy SM, Hong Y, Houston Miller N, Lauer RM, Ockene IS, Sacco RL, Sallis JF, Smith SC Jr, Stone NJ, Taubert KA. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update. Circulation. 2002;106:388-391.
5. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pasternak RC, Pearson T, Pfeffer MA, Taubert KA. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation. 2006;113:2363-2372.
6. Mosca L, Banka CL, Benjamin EJ, Berra K, Bushnell C, Dolor RJ, Ganiats T, Gomes AS, Gornick H, Gracia C, Gulati M, Haan CK, Judelson DR, Keenan N, Kelepouris E, Michos E, Oparil S, Ouyang P, Oz MC, Petitti D, Pinn VW, Redberg R, Scott R, Sherif K, Smith SC Jr, Sopko G, Steinhorn RH, Stone NJ, Taubert KA, Todd BA, Urbina E, Wenger NK. 2007 Update: American Heart Association evidence-based guidelines for cardiovascular disease prevention in women. Circulation. 2007;115:1481-1501.
7. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA, Mullany CJ, Pearle DL, Sloan MA, Smith SC Jr, for the 2005 Writing Committee Members. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. Circulation. 2008;117:296-329.
8. King SB III, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO, for the 2005 Writing Committee Members. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. Circulation. 2008;117:261-295.
9. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curts AB, Ellenbogen KA, Halperin JL, Le Heuzey J-Y, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Circulation. 2006;114:e257-e354.
10. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation. 2006;113:e463-e654.
11. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL. AHA/ASA guideline: primary prevention of ischemic stroke. Stroke. 2006;37:1583-1633.
12. Adams RJ, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston C, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Sacco RL, Schwamm LH. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke. 2008;39:1647-1652.
13. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
14. Hsia J. Pro: should aspirin be used in all omen older than 65 years to prevent stroke? Prev Cardiol. 2007;10:6-11.
15. Buring JE. Con: should aspirin be used in all women older than 65 years to prevent stroke? Prev Cardiol. 2007;10:12-18.
16. Greving JP, Buskens E, Koffijberg H, Algra A. Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk. Circulation. 2008;117:2875-2883.
17. Christian AH, Rosamond W, White AR, Mosca L. Nine-year trends and ethnic disparities in women's awareness of heart disease: an American Heart Association national study. J Womens Health (Larchmt). 2007;16:68-81.
18. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352:1293-1304.
19. Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men. JAMA. 2006;295:306-313.